As part of an executive order issued last Friday marketed as promoting economic competition, President Joe Biden directed the government to pause a proposed rule from the Trump administration that would have prevented the use of so-called “march-in rights,” which have never been used before but hypothetically could lower prescription drug costs.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,